Literature DB >> 19959686

Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.

Karen Curtin1, Wade S Samowitz, Roger K Wolff, Cornelia M Ulrich, Bette J Caan, John D Potter, Martha L Slattery.   

Abstract

DNA repair enzymes function in major pathways to reverse DNA damage, including base excision repair (BER). Missense polymorphisms in BER repair genes may contribute to differences in DNA repair capacity, specific mutations, and susceptibility to cancer in the presence of exposure to carcinogens such as cigarette smoking. In a study of 1,604 incident colon cancer cases and 1,969 matched population-based controls genotyped for BER variants OGG1 (S326C) and XRCC1 (R194W, R280H, and R399Q), we found no associations with colon cancer overall. However, a 2-fold increased risk of BRAF V600E tumor mutation was observed in current and former cigarette smokers homozygous for the OGG1 polymorphism (odds ratio, 2.2; 95% confidence interval, 1.02-4.9, recessive model); similar associations were not observed for microsatellite instability, CpG island methylator phenotype, KRAS2 mutations, or TP53 mutations. The XRCC1 R194W polymorphism was associated with a modest increased risk of TP53 tumor mutations in those who regularly smoked cigarettes (odds ratio, 1.4; 95% confidence interval, 1.02-1.9). These findings point to the importance of studying tumor mutations when examining DNA repair polymorphisms and cigarette smoke exposure to identify potentially relevant associations with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959686      PMCID: PMC2796556          DOI: 10.1158/1055-9965.EPI-09-0955

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  27 in total

1.  Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling.

Authors:  P Burton; L Gurrin; P Sly
Journal:  Stat Med       Date:  1998-06-15       Impact factor: 2.373

Review 2.  Colorectal cancer: molecules and populations.

Authors:  J D Potter
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

3.  Objective system for interviewer performance evaluation for use in epidemiologic studies.

Authors:  S Edwards; M L Slattery; M Mori; T D Berry; B J Caan; P Palmer; J D Potter
Journal:  Am J Epidemiol       Date:  1994-12-01       Impact factor: 4.897

4.  Energy balance and colon cancer--beyond physical activity.

Authors:  M L Slattery; J Potter; B Caan; S Edwards; A Coates; K N Ma; T D Berry
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

5.  Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors.

Authors:  M L Slattery; K Curtin; K Anderson; K N Ma; L Ballard; S Edwards; D Schaffer; J Potter; M Leppert; W S Samowitz
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

6.  hOGG1 Ser326Cys polymorphism modifies the significance of the environmental risk factor for colon cancer.

Authors:  Jae-Il Kim; Young-Jin Park; Ki-Hong Kim; Ji-Il Kim; Byung-Joo Song; Meung-Soo Lee; Chul-Num Kim; Seok-Hyo Chang
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

7.  Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.

Authors:  J D Potter; J Bigler; L Fosdick; R M Bostick; E Kampman; C Chen; T A Louis; P Grambsch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-01       Impact factor: 4.254

8.  Diet activity, and lifestyle associations with p53 mutations in colon tumors.

Authors:  Martha L Slattery; Karen Curtin; K Ma; Sandra Edwards; Donna Schaffer; Kristen Anderson; Wade Samowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-06       Impact factor: 4.254

9.  Quantitative evaluation of CpG island methylation in hyperplastic polyps.

Authors:  Cecily P Vaughn; Andrew R Wilson; Wade S Samowitz
Journal:  Mod Pathol       Date:  2009-10-23       Impact factor: 7.842

10.  GSTM-1 and NAT2 and genetic alterations in colon tumors.

Authors:  M L Slattery; Karen Curtin; K Ma; Donna Schaffer; John Potter; Wade Samowitz
Journal:  Cancer Causes Control       Date:  2002-08       Impact factor: 2.506

View more
  25 in total

1.  Genetic association between hOGG1 C8069G polymorphism and colorectal cancer risk.

Authors:  Xiaoge Sun; Hao Yang; Yu Lin; Jianguo Zhao; Yinna Bao; Xiulan Liu; Zhen Qi; Shaojun Wang; Congxiu Huang; Zhilong Yu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study.

Authors:  Fatima Zohra Moghtit; Meriem Samia Aberkane; Valérie Le Morvan; Lotfi Louhibi; Ricardo Bellot; Abdelkader Bousahba; Ahlem Megaiz; Mostefa Fodil; Sounnia Mediene-Benchekor; Faouzia Zemani-Fodil; Abdallah Boudjema; Jacques Robert; Nadhira Saidi-Mehtar
Journal:  Med Oncol       Date:  2014-04-01       Impact factor: 3.064

Review 3.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

4.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

5.  APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.

Authors:  Shi-Heng Zhang; Lin-Ang Wang; Zheng Li; Yu Peng; Yan-Ping Cun; Nan Dai; Yi Cheng; He Xiao; Yan-Li Xiong; Dong Wang
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

6.  Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population.

Authors:  Ye Li; Shuying Li; Zhiwei Wu; Fulan Hu; Lin Zhu; Xiaojuan Zhao; Binbin Cui; Xinshu Dong; Suli Tian; Fan Wang; Yashuang Zhao
Journal:  Med Oncol       Date:  2013-02-22       Impact factor: 3.064

7.  Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.

Authors:  Martha L Slattery; Jennifer S Herrick; Abbie Lundgreen; Francis A Fitzpatrick; Karen Curtin; Roger K Wolff
Journal:  Carcinogenesis       Date:  2010-07-09       Impact factor: 4.944

Review 8.  A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers.

Authors:  Ping-Ting Zhou; Bo Li; Jun Ji; Meng-Meng Wang; Chun-Fang Gao
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

Review 9.  Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk.

Authors:  B Karahalil; V A Bohr; D M Wilson
Journal:  Hum Exp Toxicol       Date:  2012-09-27       Impact factor: 2.903

10.  Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies.

Authors:  Li Liu; Lin Miao; Guozhong Ji; Fulin Qiang; Zheng Liu; Zhining Fan
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.